Paediatrics: how to manage obstructive sleep apnoea syndrome

Obstructive sleep apnoea syndrome (OSAS) is defined as the intermittent reduction or cessation of airflow due to partial or complete obstruction of the upper airway during sleep. Paediatric OSAS has specific contributing factors, presenting symptoms and management strategies in various age groups. U...

Full description

Bibliographic Details
Main Authors: Theresa NH Leung, James WCH Cheng, Anthony KC Chan
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2021-03-01
Series:Drugs in Context
Subjects:
Online Access:https://www.drugsincontext.com/paediatrics:-how-to-manage-obstructive-sleep-apnoea-syndrome
id doaj-3cecf153e3304c58bfc24f9fdf04c189
record_format Article
spelling doaj-3cecf153e3304c58bfc24f9fdf04c1892021-03-26T13:47:02ZengBioExcel Publishing LtdDrugs in Context1740-43981740-43982021-03-011011410.7573/dic.2020-12-5Paediatrics: how to manage obstructive sleep apnoea syndromeTheresa NH LeungJames WCH ChengAnthony KC ChanObstructive sleep apnoea syndrome (OSAS) is defined as the intermittent reduction or cessation of airflow due to partial or complete obstruction of the upper airway during sleep. Paediatric OSAS has specific contributing factors, presenting symptoms and management strategies in various age groups. Untreated OSAS can lead to detrimental effects on neurocognitive development and cardiovascular and metabolic functions of a growing child. In the past decade, practice guidelines have been developed to guide the evaluation and management of OSAS. This article provides a narrative review on the current diagnostic and treatment options for paediatric OSAS. Alternative diagnostic tools other than the standard polysomnography are discussed. Adenotonsillectomy is considered the first-line therapy yet it is not suitable for treatment of all OSAS cases. Nocturnal non-invasive positive airway pressure ventilation is effective and could be the priority treatment for patients with complex comorbidities, residual OSAS post-adenotonsillectomy or obesity. However, intolerance and non-adherence are major challenges of positive airway pressure therapy especially in young children. There is increasing evidence for watchful waiting and other gentler alternative treatment options in mild OSAS. The role of anti-inflammatory drugs as the primary or adjunctive treatment is discussed. Other treatment options, including weight reduction, orthodontic procedures and myofunctional therapy, are indicated for selected patients. Nevertheless, the successful management of paediatric OSAS often requires a multidisciplinary team approach.https://www.drugsincontext.com/paediatrics:-how-to-manage-obstructive-sleep-apnoea-syndromeadenotonsillectomyanti-inflammatory drugschildrenobstructive sleep apnoeaobstructive sleep-disordered breathingpolysomnographypositive airway pressure
collection DOAJ
language English
format Article
sources DOAJ
author Theresa NH Leung
James WCH Cheng
Anthony KC Chan
spellingShingle Theresa NH Leung
James WCH Cheng
Anthony KC Chan
Paediatrics: how to manage obstructive sleep apnoea syndrome
Drugs in Context
adenotonsillectomy
anti-inflammatory drugs
children
obstructive sleep apnoea
obstructive sleep-disordered breathing
polysomnography
positive airway pressure
author_facet Theresa NH Leung
James WCH Cheng
Anthony KC Chan
author_sort Theresa NH Leung
title Paediatrics: how to manage obstructive sleep apnoea syndrome
title_short Paediatrics: how to manage obstructive sleep apnoea syndrome
title_full Paediatrics: how to manage obstructive sleep apnoea syndrome
title_fullStr Paediatrics: how to manage obstructive sleep apnoea syndrome
title_full_unstemmed Paediatrics: how to manage obstructive sleep apnoea syndrome
title_sort paediatrics: how to manage obstructive sleep apnoea syndrome
publisher BioExcel Publishing Ltd
series Drugs in Context
issn 1740-4398
1740-4398
publishDate 2021-03-01
description Obstructive sleep apnoea syndrome (OSAS) is defined as the intermittent reduction or cessation of airflow due to partial or complete obstruction of the upper airway during sleep. Paediatric OSAS has specific contributing factors, presenting symptoms and management strategies in various age groups. Untreated OSAS can lead to detrimental effects on neurocognitive development and cardiovascular and metabolic functions of a growing child. In the past decade, practice guidelines have been developed to guide the evaluation and management of OSAS. This article provides a narrative review on the current diagnostic and treatment options for paediatric OSAS. Alternative diagnostic tools other than the standard polysomnography are discussed. Adenotonsillectomy is considered the first-line therapy yet it is not suitable for treatment of all OSAS cases. Nocturnal non-invasive positive airway pressure ventilation is effective and could be the priority treatment for patients with complex comorbidities, residual OSAS post-adenotonsillectomy or obesity. However, intolerance and non-adherence are major challenges of positive airway pressure therapy especially in young children. There is increasing evidence for watchful waiting and other gentler alternative treatment options in mild OSAS. The role of anti-inflammatory drugs as the primary or adjunctive treatment is discussed. Other treatment options, including weight reduction, orthodontic procedures and myofunctional therapy, are indicated for selected patients. Nevertheless, the successful management of paediatric OSAS often requires a multidisciplinary team approach.
topic adenotonsillectomy
anti-inflammatory drugs
children
obstructive sleep apnoea
obstructive sleep-disordered breathing
polysomnography
positive airway pressure
url https://www.drugsincontext.com/paediatrics:-how-to-manage-obstructive-sleep-apnoea-syndrome
work_keys_str_mv AT theresanhleung paediatricshowtomanageobstructivesleepapnoeasyndrome
AT jameswchcheng paediatricshowtomanageobstructivesleepapnoeasyndrome
AT anthonykcchan paediatricshowtomanageobstructivesleepapnoeasyndrome
_version_ 1724202012127526912